Immunocytochemical evidence of heterogenous origin of α-fetoprotein in immature teratoma of the ovary

David R. Burrus, Takashi Okagaki, Leo B. Twiggs, Doris C. Brooker

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

α-Fetoprotein (AFP) has been found to be clinically important in the management of patients with gynecologic malignancies. Serum AFP levels are used as tumor markers for ovarian tumors, namely endodermal sinus tumors (EST) and embryonal tumors. In two cases of immature teratoma of the ovary without a yolk sac component, evidence for AFP production was found in a wide variety of cells of both endodermal and ectodermal origin suggesting a heterogeneous origin of AFP. To complement this finding, a summary of the ontology of AFP along with current and potential uses of an antigenically active tumor marker are presented.

Original languageEnglish
Pages (from-to)73-79
Number of pages7
JournalGynecologic Oncology
Volume21
Issue number1
DOIs
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Fetal Proteins
Teratoma
Ovary
Tumor Biomarkers
Endodermal Sinus Tumor
Neoplasms
Yolk Sac
Serum

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Immunocytochemical evidence of heterogenous origin of α-fetoprotein in immature teratoma of the ovary. / Burrus, David R.; Okagaki, Takashi; Twiggs, Leo B.; Brooker, Doris C.

In: Gynecologic Oncology, Vol. 21, No. 1, 01.01.1985, p. 73-79.

Research output: Contribution to journalArticle

Burrus, David R. ; Okagaki, Takashi ; Twiggs, Leo B. ; Brooker, Doris C. / Immunocytochemical evidence of heterogenous origin of α-fetoprotein in immature teratoma of the ovary. In: Gynecologic Oncology. 1985 ; Vol. 21, No. 1. pp. 73-79.
@article{13e8758396464e749433346cc474408d,
title = "Immunocytochemical evidence of heterogenous origin of α-fetoprotein in immature teratoma of the ovary",
abstract = "α-Fetoprotein (AFP) has been found to be clinically important in the management of patients with gynecologic malignancies. Serum AFP levels are used as tumor markers for ovarian tumors, namely endodermal sinus tumors (EST) and embryonal tumors. In two cases of immature teratoma of the ovary without a yolk sac component, evidence for AFP production was found in a wide variety of cells of both endodermal and ectodermal origin suggesting a heterogeneous origin of AFP. To complement this finding, a summary of the ontology of AFP along with current and potential uses of an antigenically active tumor marker are presented.",
author = "Burrus, {David R.} and Takashi Okagaki and Twiggs, {Leo B.} and Brooker, {Doris C.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1016/0090-8258(85)90234-3",
language = "English",
volume = "21",
pages = "73--79",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Immunocytochemical evidence of heterogenous origin of α-fetoprotein in immature teratoma of the ovary

AU - Burrus, David R.

AU - Okagaki, Takashi

AU - Twiggs, Leo B.

AU - Brooker, Doris C.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - α-Fetoprotein (AFP) has been found to be clinically important in the management of patients with gynecologic malignancies. Serum AFP levels are used as tumor markers for ovarian tumors, namely endodermal sinus tumors (EST) and embryonal tumors. In two cases of immature teratoma of the ovary without a yolk sac component, evidence for AFP production was found in a wide variety of cells of both endodermal and ectodermal origin suggesting a heterogeneous origin of AFP. To complement this finding, a summary of the ontology of AFP along with current and potential uses of an antigenically active tumor marker are presented.

AB - α-Fetoprotein (AFP) has been found to be clinically important in the management of patients with gynecologic malignancies. Serum AFP levels are used as tumor markers for ovarian tumors, namely endodermal sinus tumors (EST) and embryonal tumors. In two cases of immature teratoma of the ovary without a yolk sac component, evidence for AFP production was found in a wide variety of cells of both endodermal and ectodermal origin suggesting a heterogeneous origin of AFP. To complement this finding, a summary of the ontology of AFP along with current and potential uses of an antigenically active tumor marker are presented.

UR - http://www.scopus.com/inward/record.url?scp=0021894866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021894866&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(85)90234-3

DO - 10.1016/0090-8258(85)90234-3

M3 - Article

C2 - 2580759

AN - SCOPUS:0021894866

VL - 21

SP - 73

EP - 79

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -